About This Test
c-Kit mutations are associated with shorter survival and higher relapse risk following standard AML therapy in AML Patients. It also confirms diagnosis of Systemic Mastocytosis where patients without the D816V pathogenic variation are sensitive to the tyrosine kinase inhibitor Imatinib mesylate (Imatinib).
Test Parameters (1)
- C-KIT MUTATION DETECTION PCR
Home Collection
✓ Available
Reports Available In
1 Day
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
Physician Prescription is mandatory.
This test is important for identifying C-KIT mutations to guide targeted cancer treatment and predict outcomes.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
